112 related articles for article (PubMed ID: 24188805)
21. Activation of dendritic cells by liposomes prepared from phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette-Guerin and adjuvant activity in vivo.
Sprott GD; Dicaire CJ; Gurnani K; Sad S; Krishnan L
Infect Immun; 2004 Sep; 72(9):5235-46. PubMed ID: 15322018
[TBL] [Abstract][Full Text] [Related]
22. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
[TBL] [Abstract][Full Text] [Related]
23. Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses.
Rizwan SB; McBurney WT; Young K; Hanley T; Boyd BJ; Rades T; Hook S
J Control Release; 2013 Jan; 165(1):16-21. PubMed ID: 23142776
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic-targeted cationic liposomes: a robust vaccine adjuvant for promoting long-term immunological memory.
Wang C; Liu P; Zhuang Y; Li P; Jiang B; Pan H; Liu L; Cai L; Ma Y
Vaccine; 2014 Sep; 32(42):5475-83. PubMed ID: 25110295
[TBL] [Abstract][Full Text] [Related]
25. Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response.
Brgles M; Habjanec L; Halassy B; Tomasić J
Vaccine; 2009 Sep; 27(40):5435-42. PubMed ID: 19632317
[TBL] [Abstract][Full Text] [Related]
26. Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells.
Kamath AT; Valenti MP; Rochat AF; Agger EM; Lingnau K; von Gabain A; Andersen P; Lambert PH; Siegrist CA
Eur J Immunol; 2008 May; 38(5):1247-56. PubMed ID: 18412160
[TBL] [Abstract][Full Text] [Related]
27. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric analysis of cellular changes in mice after intradermal inoculation with a liposome-iscom adjuvanted vaccine.
San Gil F; Turner B; Mullbacher A; Walker MJ; Djordjevic SP; Eamens GJ; Chin JC
Scand J Immunol; 1998 Mar; 47(3):243-53. PubMed ID: 9519863
[TBL] [Abstract][Full Text] [Related]
29. The immunological activity of propolis flavonoids liposome on the immune response against ND vaccine.
Yuan J; Liu J; Hu Y; Fan Y; Wang D; Guo L; Nguyen TL; Zhao X; Liu X; Liu C; Wu Y
Int J Biol Macromol; 2012 Nov; 51(4):400-5. PubMed ID: 22705053
[TBL] [Abstract][Full Text] [Related]
30. Haemolytic activity and adjuvant effect of soyasaponins and some of their derivatives on the immune responses to ovalbumin in mice.
Qiao N; Liu Q; Meng H; Zhao D
Int Immunopharmacol; 2014 Feb; 18(2):333-9. PubMed ID: 24374303
[TBL] [Abstract][Full Text] [Related]
31. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses.
Boscardin SB; Hafalla JC; Masilamani RF; Kamphorst AO; Zebroski HA; Rai U; Morrot A; Zavala F; Steinman RM; Nussenzweig RS; Nussenzweig MC
J Exp Med; 2006 Mar; 203(3):599-606. PubMed ID: 16505139
[TBL] [Abstract][Full Text] [Related]
32. The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant.
Liu X; Wetzler LM; Massari P
Vaccine; 2008 Feb; 26(6):786-96. PubMed ID: 18191311
[TBL] [Abstract][Full Text] [Related]
33. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
[TBL] [Abstract][Full Text] [Related]
34. Vaccination with Antigen Combined with αβ-ATP as a Vaccine Adjuvant Enhances Antigen-Specific Antibody Production via Dendritic Cell Activation.
Matsuo K; Nishiuma S; Hasegawa Y; Kawabata F; Kitahata K; Nakayama T
Biol Pharm Bull; 2016; 39(6):1073-6. PubMed ID: 27251512
[TBL] [Abstract][Full Text] [Related]
35. Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants.
Sokolovska A; Hem SL; HogenEsch H
Vaccine; 2007 Jun; 25(23):4575-85. PubMed ID: 17485153
[TBL] [Abstract][Full Text] [Related]
36. Human Flt-3-ligand-mobilized dendritic cells require additional activation to drive effective immune responses.
Diener KR; Moldenhauer LM; Lyons AB; Brown MP; Hayball JD
Exp Hematol; 2008 Jan; 36(1):51-60. PubMed ID: 17949888
[TBL] [Abstract][Full Text] [Related]
37. Phosphatidylinositol mannosides are efficient mucosal adjuvants.
Parlane NA; Denis M; Severn WB; Skinner MA; Painter GF; La Flamme AC; Ainge GD; Larsen DS; Buddle BM
Immunol Invest; 2008; 37(2):129-42. PubMed ID: 18300038
[TBL] [Abstract][Full Text] [Related]
38. Polysaccharides from Ganoderma formosanum function as a Th1 adjuvant and stimulate cytotoxic T cell response in vivo.
Pi CC; Chu CL; Lu CY; Zhuang YJ; Wang CL; Yu YH; Wang HY; Lin CC; Chen CJ
Vaccine; 2014 Jan; 32(3):401-8. PubMed ID: 24252697
[TBL] [Abstract][Full Text] [Related]
39. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
Wang X; Uto T; Akagi T; Akashi M; Baba M
J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
[TBL] [Abstract][Full Text] [Related]
40. CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations.
Christensen D; Foged C; Rosenkrands I; Lundberg CV; Andersen P; Agger EM; Nielsen HM
Int J Pharm; 2010 May; 390(1):19-24. PubMed ID: 19879346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
